検索ワード: acinetobacter (ラトビア語 - 英語)

acinetobacter
acinetobacter

acinetobacter sugas.
acinetobacter spp.

acinetobacter baumannii enterobacter spp.
acinetobacter baumannii enterobacter spp.

produkts, ko iegūst fermentācijā ar baktēriju acinetobacter
product obtained by the fermentation of acinetobacter

gramnegatīvas aerobas baktērijas acinetobacter enterobacteriaceae pseudomonas s air
aerobic gram- negative bacteria acinetobacter enterobacteriaceae pseudomonas t uc

acinetobacter baumannii * acinetobacter sugas burkholderia cepacia$+ pseudomonas aeruginosa
burkholderia cepacia$+ pseudomanas aeruginosa*

acinetobacter spp. ≤ 1 µg/ ml jūtīgām, > 1 µg/ ml rezistentām;
- acinetobacter spp. ≤ 1 µg/ ml for susceptible, > 1 µg/ ml for resistant;

gramnegatīvie aerobie: aeromonas ģintis acinetobacter ģintis burkholderia cepacia pseudomonas aeruginosa stenotrophomonas maltophilia
gram-negative aerobes: aeromonas species acinetobacter species burkholderia cepacia pseudomonas aeruginosa stenotrophomonas maltophilia

streptoococus agalactiae streptococcus pneumoniae s. pneumoniae pen- r streptococcus pyogenes gramnegatīvie aerobi acinetobacter spp.
streptoococus agalactiae streptococcus pneumoniae s. pneumoniae pen-r streptococcus pyogenes gram-negative aerobes acinetobacter spp.

s ≤1 mg/ l un r > 4 mg/ l ar sugām nesaistīti stafilokoki enterobacteriaceae acinetobacter sugas
s ≤1 mg/l and r > 4 mg/l inferred from the methicillin breakpoint

acinetobacter sugas. ≤1 µg/ ml jutīgiem organismiem, > 1 µg/ ml rezistentiem organismiem;
- acinetobacter spp. ≤ 1 µg/ ml for susceptible, > 1 µg/ ml for resistant;

sugas, kurām iegūta rezistence var būt problēma acinetobacter baumannii bacteroides fragilis grupa † burkholderia cepacia morganella morganii providencia spp.
species for which acquired resistance may be a problem acinetobacter baumannii bacteroides fragilis group† burkholderia cepacia morganella morganii providencia spp.

pseudomonas aeruginosa, acinetobacter, staphylococcus aureus) zemāka uzņēmība un slimības smaguma pakāpe (kā arī grūtības sasniegt optimālo koncentrāciju kaulu līmenī).
posology for severe respiratory tract infections, severe bone and joint infections in severe respiratory tract infections as well as in severe bone and joint infections, higher doses than that currently recommended (such as 750 mg x 3/ day or 1000 mg x 2/ day) for oral route are currently used in clinical practice given the known decreased susceptibility of the main pathogens involved (including pseudomonas aeruginosa, acinetobacter, staphylococcus aureus) and the severity of the disease (as well as the difficulties in reaching optimal concentration at the bone level).

129 bacillus anthracis (1) aerobie gram- negatīvie mikroorganismi aeromonas sugas brucella sugas citrobacter koseri francisella tularensis haemophilus ducreyi haemophilius influenzae * legionella sugas moraxella catarrhalis * neisseria meningitidis pasteurella sugas salmonella sugas * shigella sugas * vibrio sugas yersinia pestis anaerobie mikroorganismi mobiluncus citi mikroorganismi chlamydia trachomatis ($) chlamydia pneumoniae ($) mycoplasma hominis ($) mycoplasma pneumoniae ($) sugas, kurĀm varĒtu bŪt iegŪta rezistence aerobie gram- pozitīvie mikroorganismi enterococcus faecalis ($) staphylococcus spp. * (2) aerobie gram- negatīvie mikroorganismi acinetobacter baumannii+ burkholderia cepacia+ * campylobacter sugas+ * citrobacter freundii * enterobacter aerogenes enterobacter cloacae * escherichia coli * klebsiella oxytoca klebsiella pneumoniae * morganella morganii * neisseria gonorrhoeae * proteus mirabilis * proteus vulgaris * providencia sugas pseudomonas aeruginosa * pseudomonas fluorescens serratia marcescens * anaerobie mikroorganismi peptostreptococcus sugas propionibacterium acnes mikroorganismi ar pĀrmantotu rezistenci aerobie gram- pozitīvie mikroorganismi actinomyces enteroccus faecium listeria monocytogenes aerobie gram- negatīvie mikroorganismi stenotrophomonas maltophilia
propionibacterium acnes